Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford to take the high risk of losing your money.

69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

5 Top Stories

Tencent Pops on Launch Announcement

Every day, we handpick the 5 Top Stories stock market investors need to know. In 5 minutes, you’ll learn the stocks, CEOs, and money managers moving markets.

Tencent Pops on Launch Announcement

The Tencent [0700:HK] share price has logged its biggest rally since last December, following the announcement of a 21 May launch for the Dungeon & Fighter Mobile game in China. Developed by South Korea’s Nexon [3659:T], the marquee title has been in progress for several years. “We expect gaming revenue to turn around in Q2 2024,” Jefferies analyst Thomas Chong wrote in a note seen by Bloomberg; he predicts that the game could generate $828m annually.

EV Price War Gets Nastier

“Tesla prices must change frequently in order to match production with demand,” CEO Elon Musk wrote on X this weekend, as Tesla [TSLA] announced it is to slash prices across its range, in markets including Germany and China. Now, Li Auto [LI] has announced 6–7% price cuts across its line-up, and offered cash rebates to owners of 2024 models. Tesla reports Q1 earnings on Tuesday.

What Does This Week Hold for Chip Stocks?

According to Bloomberg, the number of put options on the chipmaker’s [TSM] US-listed shares hit their highest level since January on Friday. The stock had lost 13% over the six sessions prior to Monday, wiping out more than $100bn in market value. Nvidia [NVDA] and Super Micro Computer [SMCI] also fell sharply on Friday. Investors will be closely following all three stocks’ progress this week, amid concerns that the artificial intelligence market is shrinking.

New Obesity Drugs Set to Flood Market

A new report by Global Data details that some 13 new weightloss treatments could be released in the US over the next five years. The report also details how sales of the drug have skyrocketed recently: Novo Nordisk’s [NVO] Wegovy and Eli Lilly’s [LLY] Zepbound together raised $9.7bn in global sales in 2023; Novo Nordisk is set to launch six products in the next five years.

Salesforce and Informatica: So Over

The Wall Street Journal reported earlier this month that San Franciso-based cloud software firm Salesforce [CRM] was set to make what would have been one of its biggest-ever moves: the acquisition of software developer Informatica [INFA]. That deal, which might have been worth some $10bn, is now off the table, after the two firms failed to agree on terms. Informatica shares opened Monday 5.5% lower following the news.

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

Latest articles